Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02510040 · ClinicalTrials.gov registry record
A Prospective Observational Study of Adult Strabismus
A clinical trial of Convergence Insufficiency and Divergence Insufficiency, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- 217
- Enrollment target
- 1
- Study location
NCT02510040 is a study of Convergence Insufficiency and Divergence Insufficiency that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 217 participants, above the 90-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target (141% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02510040, a study of Convergence Insufficiency and Divergence Insufficiency, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.
Conditions Studied
Interventions
- DEVICE Prism
- OTHER Orthoptic Exercises
- PROCEDURE Eye Muscle Surgery
- PROCEDURE Botox Injection
Study Locations (1)
Virginia
- Earl R. Crouch, III - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2015-08-17 |
| Est. Completion | 2019-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02510040
The ClinicalTrials.gov registry entry for NCT02510040 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 90-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target (141% higher). The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Convergence Insufficiency appearing as the primary indexed condition, and to 4 interventions - of which Prism is the first listed.
NCT02510040 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02510040 about?
NCT02510040 is a clinical study titled "A Prospective Observational Study of Adult Strabismus". The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.
What is the current status of trial NCT02510040?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2015-08-17. Estimated completion is 2019-01-31.
What conditions does trial NCT02510040 study?
This clinical trial studies the following conditions: Convergence Insufficiency, Divergence Insufficiency, Hypertropia.
What interventions are being tested in trial NCT02510040?
The interventions under investigation include: Prism (DEVICE), Orthoptic Exercises (OTHER), Eye Muscle Surgery (PROCEDURE), Botox Injection (PROCEDURE).
Who is sponsoring clinical trial NCT02510040?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02510040 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Convergence Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home-based Vision Therapy
RECRUITING · Phase 1
-
Effectiveness of Virtual Reality Vision Therapy - VERVE
RECRUITING · Early Phase 1
-
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
RECRUITING · NA
-
Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency
RECRUITING · NA
-
Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency
COMPLETED · NA
-
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.